@Article{rjees738,
AUTHOR = {Kumar, Gaurav},
TITLE = {Critical Success Factors of Adopting an Enterprise System for Pharmaceutical Drug Traceability},
JOURNAL = {Research Journal of Ecology and Environmental Sciences},
VOLUME = {2},
YEAR = {2023},
NUMBER = {1},
PAGES = {3-10},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/738},
ISSN = {2770-5536},
DOI = {10.31586/ujpp.2023.738},
ABSTRACT = {For conducting advanced analytics initiatives to acquire in-depth data into usage habits, regional access, sales, and promotional success, etc., unique identification of packaged pharmaceuticals will be a fantastic enabler. The main objective of this study is to prevent and reduce the production of erroneous and counterfeit drugs using the enterprise system, which has become a serious threat because it damages the reputation of legitimate drug manufacturers by trying to produce and market placebo medications that are identical to the real thing. Due to federal government procedures and priorities that frequently change over time, the majority of implementation takes time. To achieve compliance with numerous federal regulatory authorities, including drug traceability for patient safety, the pharmaceutical industry must implement a systematic procedure in an ERP environment. The goals would be to guarantee medical drug traceability and provide real-time warnings to supply chain stakeholders and regulatory bodies to maximize the benefit of integrating a drug traceability system into an ERP environment. Additionally, manufacturers are compelled to maintain product costs on the higher side due to a heavy burden of unchecked manufacturing cost spikes. As a result, innovative marketing schemes must be introduced in order to increase the reach to consumers by putting into practice successful strategies.},
}

%0 Journal Article
%A Kumar, Gaurav
%D 2023
%J Research Journal of Ecology and Environmental Sciences

%@ 2770-5536
%V 2
%N 1
%P 3-10

%T Critical Success Factors of Adopting an Enterprise System for Pharmaceutical Drug Traceability
%M doi:10.31586/ujpp.2023.738
%U https://www.scipublications.com/journal/index.php/UJPP/article/view/738

TY  - JOUR
AU  - Kumar, Gaurav
TI  - Critical Success Factors of Adopting an Enterprise System for Pharmaceutical Drug Traceability
T2  - Research Journal of Ecology and Environmental Sciences
PY  - 2023
VL  - 2
IS  - 1
SN  - 2770-5536
SP  - 3
EP  - 10
UR  - https://www.scipublications.com/journal/index.php/UJPP/article/view/738
AB  - For conducting advanced analytics initiatives to acquire in-depth data into usage habits, regional access, sales, and promotional success, etc., unique identification of packaged pharmaceuticals will be a fantastic enabler. The main objective of this study is to prevent and reduce the production of erroneous and counterfeit drugs using the enterprise system, which has become a serious threat because it damages the reputation of legitimate drug manufacturers by trying to produce and market placebo medications that are identical to the real thing. Due to federal government procedures and priorities that frequently change over time, the majority of implementation takes time. To achieve compliance with numerous federal regulatory authorities, including drug traceability for patient safety, the pharmaceutical industry must implement a systematic procedure in an ERP environment. The goals would be to guarantee medical drug traceability and provide real-time warnings to supply chain stakeholders and regulatory bodies to maximize the benefit of integrating a drug traceability system into an ERP environment. Additionally, manufacturers are compelled to maintain product costs on the higher side due to a heavy burden of unchecked manufacturing cost spikes. As a result, innovative marketing schemes must be introduced in order to increase the reach to consumers by putting into practice successful strategies.
DO  - Critical Success Factors of Adopting an Enterprise System for Pharmaceutical Drug Traceability
TI  - 10.31586/ujpp.2023.738
ER  -